Detalhe da pesquisa
1.
A library of quantitative markers of seizure severity.
Epilepsia;
64(4): 1074-1086, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36727552
2.
External validation of the QLifetime cardiovascular risk prediction tool: population cohort study.
BMC Cardiovasc Disord;
23(1): 194, 2023 04 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37061672
3.
Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study.
BMC Med;
20(1): 152, 2022 05 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35505353
4.
Development and validation of a cardiovascular risk prediction model in type 1 diabetes.
Diabetologia;
64(9): 2001-2011, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34106282
5.
Serum kidney injury molecule 1 and ß2-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetes.
Diabetologia;
62(1): 156-168, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30288572
6.
Incidence of Hospitalization for Heart Failure and Case-Fatality Among 3.25 Million People With and Without Diabetes Mellitus.
Circulation;
138(24): 2774-2786, 2018 12 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29950404
7.
Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012-2014): a population-based observational study.
Diabetologia;
61(1): 108-116, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29075822
8.
Modelling cumulative exposure for inference about drug effects in observational studies.
Pharmacoepidemiol Drug Saf;
26(12): 1527-1533, 2017 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29024286
9.
Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS).
Diabetologia;
59(2): 299-306, 2016 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26577796
10.
Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial.
Diabetologia;
58(7): 1494-502, 2015 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25899452
11.
Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes.
Diabetologia;
58(6): 1363-71, 2015 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25740695
12.
Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010.
JAMA;
313(1): 37-44, 2015 Jan 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25562264
13.
The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis.
Health Soc Care Deliv Res;
12(4): 1-275, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38420962
14.
Derivation and validation of the CFracture competing risk fracture prediction tool compared with QFracture in older people and people with comorbidity: a population cohort study.
Lancet Healthy Longev;
4(1): e43-e53, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36610448
15.
Vitamin D Deficiency (VDD) and Susceptibility towards Severe Dengue Fever-A Prospective Cross-Sectional Study of Hospitalized Dengue Fever Patients from Lahore, Pakistan.
Trop Med Infect Dis;
8(1)2023 Jan 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36668950
16.
Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a).
J Lipid Res;
53(5): 1000-1011, 2012 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22368281
17.
Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study.
PLoS Med;
9(10): e1001321, 2012.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23055834
18.
Effect of competing mortality risks on predictive performance of the QFracture risk prediction tool for major osteoporotic fracture and hip fracture: external validation cohort study in a UK primary care population.
BMJ Med;
1(1): e000316, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36936595
19.
Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19-Results From a Pilot Open-Label, Randomized Controlled Trial.
Front Pharmacol;
13: 898062, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35747751
20.
Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study.
Lancet Healthy Longev;
2(6): e352-e361, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34100008